BioXcel Therapeutics (BTAI) Interest Coverage Ratio (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Interest Coverage Ratio of 2.44 for Q1 2026, up 3.72% year-over-year from 2.35 in Q1 2025, and down 168.64% quarter-over-quarter from 3.55 in Q4 2025.
BioXcel Therapeutics (BTAI) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 2.44 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 3.72% year-over-year to 2.44; the TTM figure through Mar 2026 stood at 5.35 (up 13.48% YoY), while the FY2025 annual figure was 2.97, down 748.97% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.44, down from 3.55 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 3.64 in Q4 2024, with the low at 9.64 in Q4 2023.
- The 5-year median for Interest Coverage Ratio is 2.53 (2025), against an average of 2.85.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio plunged 2057.07% in 2023, then soared 137.75% in 2024.
- BioXcel Therapeutics' Interest Coverage Ratio stood at 0.45 in 2022, then slumped by 2057.07% to 9.64 in 2023, then jumped by 137.75% to 3.64 in 2024, then slipped by 2.48% to 3.55 in 2025, then sank by 168.64% to 2.44 in 2026.
- Business Quant data shows BTAI's Interest Coverage Ratio at 2.44 in Q1 2026, 3.55 in Q4 2025, and 3.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | -2.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.39 |
| Mar 31, 2026 | -2.44 |
| Dec 31, 2025 | 3.55 |
| Sep 30, 2025 | -3.62 |
| Jun 30, 2025 | -3.75 |
| Mar 31, 2025 | -2.53 |
| Dec 31, 2024 | 3.64 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | -4.67 |
| Mar 31, 2024 | -6.70 |
| Dec 31, 2023 | -9.64 |
| Sep 30, 2023 | -6.60 |
| Jun 30, 2023 | -5.69 |
| Mar 31, 2023 | -1.42 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -1.91 |
| Jun 30, 2022 | -1.53 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -4,355.17 |
| Sep 30, 2021 | -0.40 |